Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03737877
Other study ID # SMEC_2017-18_132
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date May 14, 2019
Est. completion date July 2019

Study information

Verified date June 2019
Source St Mary's University College
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim is to conduct a feasibility pilot study of a dietary intervention designed to optimise gut bacteria in children diagnosed with ADHD.


Description:

Children with Attention Deficit Hyperactivity Disorder (ADHD) can suffer debilitating symptoms, including problematic behaviour and sleep. Research suggests dietary manipulations may be a helpful treatment option for children with ADHD, although the most effective are highly restrictive, with little known about why they might work. Optimising gut bacteria in individuals with ADHD may help alleviate some of the symptoms of this condition via the gut-brain-axis and would provide a plausible mechanism by which dietary interventions operate. We propose to conduct a feasibility pilot study of a dietary intervention designed to optimise gut bacteria in children diagnosed with ADHD.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 9
Est. completion date July 2019
Est. primary completion date July 2019
Accepts healthy volunteers No
Gender All
Age group 8 Years to 13 Years
Eligibility Inclusion Criteria:

1. Parent-reported diagnosis of ADHD.

2. Children aged between 8 years - 13 years 11 months at onset of study.

3. Children not taking ADHD medication (such as methylphenidate) at the time of the study.

4. Parental permission to attend three group sessions and for themselves and their child to complete the requisite assessments.

5. Both males and females are eligible to take part.

6. Children with a co-occurring diagnosis will be accepted onto the trial.

7. Children with food allergies/sensitivities/coeliac disease will be accepted onto the trial.

Exclusion Criteria:

1. Children undergoing a current course of behavioural therapy.

2. Children currently on ADHD medication (such as methylphenidate).

3. Children who have taken antibiotics in the past 3 months

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Diet modification
The parents will have four group sessions with a nutritional therapist, where in depth advice and information about the diet will be provided. Ongoing support will also be provided throughout the study by use of a closed Facebook or WhatsApp group (whichever the parents choose as most appropriate). The diet is based on five main principles: Eat at least seven portions of different varieties of fruit and vegetables each day. Have a 12 hour overnight break from food (water only during this time). Drink a Kefir drink each day - provided free of charge. Eat a microbiome friendly, protein rich, breakfast from our menu. Reduce sugar and artificial sweeteners.

Locations

Country Name City State
United Kingdom St Mary's University London

Sponsors (2)

Lead Sponsor Collaborator
St Mary's University College Goldsmiths, University of London

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Completion of study What proportion of participants completed the study? final week
Secondary Adherence to diet Percentage adherence to diet over the 4-week period based on parental report (range 0-100 % - high score reflecting greater degree of adherence). week 6 of diet
Secondary Side-effects Parent-reported side effects during course of study. (Qualitative) (More/more side-effects reflect poorer outcome). duration of the 6 week diet
Secondary The Conners Clinical Index (Conners CI) - Parent-report Parental report of clinical symptoms (percentile score - higher score reflects more/more severe symptoms)
Disruptive Behavior Indicator
Learning and Language Disorder Indicator
Mood Disorder Indicator
Anxiety Disorder Indicator
ADHD Indicator
Baseline and week 6 of diet
Secondary The Conners Clinical Index (Conners CI) - Teacher-report Teacher report of clinical symptoms (percentile score - higher score reflects more/more severe symptoms)
Disruptive Behavior Indicator
Learning and Language Disorder Indicator
Mood Disorder Indicator
Anxiety Disorder Indicator
ADHD Indicator
Baseline and week 6 of diet
Secondary The Conners Clinical Index (Conners CI) - Self-report Child self-report of clinical symptoms (percentile score - higher score reflects more/more severe symptoms)
Disruptive Behavior Indicator
Learning and Language Disorder Indicator
Mood Disorder Indicator
Anxiety Disorder Indicator
ADHD Indicator
Baseline and week 6 of diet
Secondary Delayed Match to Sample test (Cambridge Neuropsychological Test Automated Battery - CANTAB) Latency (response time) Accuracy (correct patterns selected). Computerised test of visual working memory
DMS Percent Correct (overall, for all delays, simultaneous, 0 sec delay, 4 sec delay, 12 sec delay). Range 0-100% - higher score reflects greater accuracy.
DMS Mean & Median Correct Latency (overall, for all delays, simultaneous, 0 sec delay, 4 sec delay, 12 sec delay). Range 0-8 ms - higher score reflects worse performance.
DMS Correct Latency Standard Deviation. Range 0-8 ms - higher score reflects worse performance.
DMS Mean Choices to Correct response. Range 0-4 - higher score reflects worse performance.
DMS Probability of Error Given Error. Range 0-1 - higher score reflects worse performance.
Baseline and week 6 of diet
Secondary The Consensus Sleep Diary Record of sleep - used qualitatively to detect and remove artefacts from the data. Baseline and week 6 of diet
Secondary Children's Sleep Habits Questionnaire Parental report of child's sleep A Total Sleep Disturbances score is calculated as the sum of all CSHQ scored questions, and can range from 33 to 99. A higher score indicates more problematic sleep. Baseline and week 6 of diet
Secondary Sleep self-report questionnaire Week long retrospective sleep survey (Scores range from 13-39 with a higher score indicating more/more severe sleep difficulties). Baseline and week 6 of diet
Secondary Actigraphy recordings Objective measure of sleep quality and daytime activity
Mean activity during sleep. Range 0-8. A higher score = less sound sleep (worse).
Minutes spent awake during the down period. Range 0-8. A higher score = less sound sleep (worse).
Sleep latency (time taken to fall asleep). Range 0-8. A higher score = more time taken to fall asleep (worse).
Sleep efficiency (% down period spent asleep, after removing sleep latency). A higher score = better.
Wake after sleep onset (minutes spent awake during the down period after removing sleep latency). Range 0-8. A higher score = less sound sleep (worse).
Sleep fragmentation (number of awakenings/ total minutes of sleep x 100) - Higher score = more fragmented sleep (worse).
Mean daytime activity (0-8) not necessarily worse or better.
Baseline and week 6 of diet
Secondary The Gastrointestinal Symptom Rating Questionnaire to evaluate common gastrointestinal symptoms Total scores range from 15-105 (with higher scores reflecting more/more severe gastrointestinal symptoms).
Subscales:
Abdominal pain (abdominal pain, hunger pains and nausea). Range 3-21 - a high score reflects worse symptoms.
Reflux syndrome (heartburn and acid regurgitation). Range 3-21 - a high score reflects worse symptoms.
Diarrhoea syndrome (diarrhoea, loose stools and urgent need for defecation). Range 3-21 - a high score reflects worse symptoms.
Indigestion syndrome (borborygmus, abdominal distension, eructation and increased flatus). Range 3-21 - a high score reflects worse symptoms. Range 3-21 - a high score reflects worse symptoms.
Constipation syndrome (constipation, hard stools and feeling of incomplete evacuation). Range 3-21 - a high score reflects worse symptoms.
Baseline and week 6 of diet
Secondary Stool sample analysis for commensal bacteria and microbial diversity using 16S rRNA sequencing Analysis of bacterial strains and diversity within stool sample Baseline and week 6 of diet
Secondary Treatment Acceptability Scale Questionnaire to assess the acceptability of the diet to parents of the children taking part in the study Score range 6-42 (High score reflects more positive attitude to treatment) Baseline and week 6 of diet
See also
  Status Clinical Trial Phase
Completed NCT03148782 - Brain Plasticity Underlying Acquisition of New Organizational Skills in Children-R61 Phase N/A
Recruiting NCT06038942 - Formal Versus Informal Mindfulness Among University Students With Self-reported ADHD, Nonsuicidal Self-injury, or Stress N/A
Not yet recruiting NCT06456372 - Digital Health Intervention for Children With ADHD N/A
Completed NCT05518435 - Managing Young People With ADHD in Primary Care Study
Active, not recruiting NCT04978792 - Does Cultivating Self-compassion Improve Resilience to Criticism and Improve Mental Health in Adults With ADHD? N/A
Completed NCT03216512 - Effects of Noise Cancelling Headphones on Neurocognitive and Academic Outcomes in ADHD N/A
Completed NCT02900144 - Modified Comprehensive Behavioral Intervention for Tics (M_CBIT) N/A
Completed NCT02829528 - Little Flower Yoga for Kids: Evaluation of a Yoga and Mindfulness Program for Children With Increased Levels of Emotion Dysregulation and Inattention N/A
Not yet recruiting NCT02906501 - Effect of Risperidone on Cognitive Functions in Adolescents With ADHD and Behavioral Disturbances N/A
Completed NCT02562469 - ACTIVATE: A Computerized Training Program for Children With ADHD N/A
Terminated NCT02271880 - Improving Medication Adherence in ADHD Adolescents N/A
Recruiting NCT02255565 - Dose Response Effects of Quillivant XR in Children With ADHD and Autism: A Pilot Study Phase 4
Completed NCT02463396 - Mindfulness Training in Adults With ADHD N/A
Terminated NCT01733680 - Amiloride Hydrochloride as an Effective Treatment for ADHD Early Phase 1
Completed NCT01673594 - Prevention of Stimulant-Induced Euphoria With an Opioid Receptor Antagonist Phase 4
Completed NCT02300597 - Internet-based Support for Young People With ADHD and Autism - a Controlled Study N/A
Active, not recruiting NCT01137318 - Combined Cognitive Remediation and Behavioral Intervention for Treatment of Attention-deficit/Hyperactivity Disorder (ADHD) Phase 2
Completed NCT01404273 - Functional MRI of Relaxation Response Training in Adults With Attention-Deficit/Hyperactivity Disorder N/A
Completed NCT00586157 - Study of Medication Patch to Treat Children Ages 6-12 With ADHD Phase 4
Completed NCT00573859 - The Reinforcing Mechanisms of Smoking in Adult ADHD Phase 1/Phase 2